Sugarmade Issues Letter to Shareholders on Verticalization, Expansion and the Path Ahead in 2021
January 7, 2021
Ryan Allway January 7th, 2021 News, Top News MONROVIA, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Sugarmade, Inc. (OTCMKTS:SGMD) (“Sugarmade” or the “Company”) is pleased to issue the following Letter to Shareholders: Dear Valued Shareholder, We would like to express our gratitude for your patience and... Read more
NeonMind Commences Trading Under CSE Ticker Symbol “NEON”
January 4, 2021
Ryan Allway January 4th, 2021 Psychedelics, Top News NeonMind completed its oversubscribed Initial Public Offering on December 30, 2020, for gross proceeds of $4,600,000. NeonMind is a psychedelic drug development company. It’s mission is to help people change their lives by changing their minds, through treatment with psychedelics. NeonMind’s... Read more
Eden Empire Sets Date to Commence Trading on the CSE
January 4, 2021
Ryan Allway January 4th, 2021 News, Top News VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden”) is pleased to announce that its common shares will commence trading effective at the open of the Canadian Securities Exchange (“CSE”) on Monday,... Read more
Rubicon Organics Receives First Purchase Order from Quebec
January 4, 2021
Ryan Allway January 4th, 2021 News, Top News Launching Rubicon Organics’ third brand, 1964™ exclusive to Quebec Product innovation portfolio continues to expand with the launch of hash VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”),... Read more
The Canadian Securities Exchange (The CSE), CFN Media and Zuber Lawler Announce Their Latest “Investing in Psychedelics” Virtual Conference Series
December 23, 2020
Ryan Allway December 23rd, 2020 News, Top News Whitefish, Montana–(Newsfile Corp. – December 23, 2020) – CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media platform dedicated to the global legal cannabis, CBD and psychedelics industries, today announced its second free, co-branded, global, live virtual... Read more
CLC Enters Sales and Marketing Phase Producing First Commercial Cannabis-Derived Crude Oil, and Introduces Two Extraction Specialists
December 23, 2020
Ryan Allway December 23rd, 2020 VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it has produced its first batch of cannabis-derived crude oil produced using its Vitalis R-200-H-GMP-SS extraction system... Read more
Cannabics Pharmaceuticals Initiates In-Vivo Animal Studies for FDA Pre-IND Meeting Package
December 21, 2020
Ryan Allway December 21st, 2020 News, Top News TEL AVIV, Israel and BETHESDA, Maryland, Dec. 21, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based therapeutic formulations and medicines, announced today that it has initiated a series of proof of concept (POC), in-vivo, animal model studies to... Read more
Psychedelics Production Challenges & Solutions
December 21, 2020
Ryan Allway December 21st, 2020 App, Exclusive, Psychedelics, Top News Psilocybin and other tryptamine-based compounds could become blockbuster therapeutics for the treatment of depression, post-traumatic stress disorder and other difficult to treat psychiatric conditions. While many clinical trials are underway, researchers are turning their attention toward the problem of... Read more
Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials
December 21, 2020
Ryan Allway December 21st, 2020 Psychedelics, Top News DENVER, Dec. 21, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that... Read more
Christina Lake Cannabis Announces Genetic Databank With Portfolio of Over 100 Proprietary Strains for Outdoor Growth, and Total Inventory of 600,000+ Seeds
December 18, 2020
Ryan Allway December 18th, 2020 News, Top News VANCOUVER, British Columbia, Dec. 18, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that after its inaugural growing season in which the Company produced 32,500 kg / 71,650... Read more
